View Item 

Show simple item record

The Relative Merits of Population-Based and Targeted Prevention Strategies

dc.contributor.authorZulman, Donna M.en_US
dc.contributor.authorVijan, Sandeepen_US
dc.contributor.authorOmenn, Gilbert S.en_US
dc.contributor.authorHayward, Rodney A.en_US
dc.date.accessioned2010-06-01T19:50:28Z
dc.date.available2010-06-01T19:50:28Z
dc.date.issued2008-12en_US
dc.identifier.citationZULMAN, DONNA M.; VIJAN, SANDEEP; OMENN, GILBERT S.; HAYWARD, RODNEY A. (2008). "The Relative Merits of Population-Based and Targeted Prevention Strategies." Milbank Quarterly 86(4): 557-580. <http://hdl.handle.net/2027.42/72973>en_US
dc.identifier.issn0887-378Xen_US
dc.identifier.issn1468-0009en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72973
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19120980&dopt=citationen_US
dc.format.extent159182 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rights© 2008 Milbank Memorial Funden_US
dc.subject.otherRisk Stratificationen_US
dc.subject.otherPreventionen_US
dc.subject.otherMultivariable Prediction Toolsen_US
dc.subject.otherCholesterolen_US
dc.titleThe Relative Merits of Population-Based and Targeted Prevention Strategiesen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan; VA Ann Arbor Healthcare Systemen_US
dc.identifier.pmid19120980en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72973/1/j.1468-0009.2008.00534.x.pdf
dc.identifier.doi10.1111/j.1468-0009.2008.00534.xen_US
dc.identifier.sourceMilbank Quarterlyen_US
dc.identifier.citedreferenceAnderson, K.M., P.M. Odell, P.W. Wilson, and W.B. Kannel. 1991. Cardiovascular Disease Risk Profiles. American Heart Journal 121 ( 1, pt. 2 ): 293 – 98.en_US
dc.identifier.citedreferenceAvins, A.L., and W.S. Browner. 1998. Improving the Prediction of Coronary Heart Disease to Aid in the Management of High Cholesterol Levels: What a Difference a Decade Makes. Journal of the American Medical Association 279: 445 – 49.en_US
dc.identifier.citedreferenceCheung, R., M.D. Altschuler, A.V. D'Amico, S.B. Malkowicz, A.J. Wein, and R. Whittington. 2001. Using the Receiver Operating Characteristic Curve to Select Pretreatment and Pathologic Predictors for Early and Late Postprostatectomy PSA Failure. Urology 58: 400 – 5.en_US
dc.identifier.citedreferenceEmberson, J., P. Whincup, R. Morris, M. Walker, and S. Ebrahim. 2004. Evaluating the Impact of Population and High-Risk Strategies for the Primary Prevention of Cardiovascular Disease. European Heart Journal 25: 484 – 91.en_US
dc.identifier.citedreferenceEmpana, J.P., P. Ducimetiere, D. Arveiler, J. Ferrieres, A. Evans, J.B. Ruidavets, B. Haas, J. Yarnell, A. Bingham, P. Amouyel, and J. Dallongeville. 2003. PRIME Study Group. Are the Framingham and PROCAM Coronary Heart Disease Risk Functions Applicable to Different European Populations ? European Heart Journal 24: 1903 – 11.en_US
dc.identifier.citedreferenceFerrario, M., P. Chiodini, L.E. Chambless, G. Cesana, D. Vanuzzo, S. Panico, R. Sega, L. Pilotto, L. Palmieri, and S. Giampaoli. 2005. CUORE Project Research Group. Prediction of Coronary Events in a Low Incidence Population. Assessing Accuracy of the CUORE Cohort Study Prediction Equation. International Journal of Epidemiology 34 ( 2 ): 413 – 21.en_US
dc.identifier.citedreferenceFiaccadori, E., U. Maggiore, M. Lombardi, S. Leonardi, C. Rotelli, and A. Borghetti. 2000. Predicting Patient Outcome from Acute Renal Failure Comparing Three General Severity of Illness Scoring Systems. Kidney International 58: 283 – 92.en_US
dc.identifier.citedreferenceGage, B.F., A.B. Cardinalli, G.W. Albers, and D.K. Owens. 1995. Cost-Effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients with Nonvalvular Atrial Fibrillation. Journal of the American Medical Association 274 ( 23 ): 1839 – 45.en_US
dc.identifier.citedreferenceGoldman, L., M.C. Weinstein, P.A. Goldman, and L.W. Williams. 1991. Cost-Effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart Disease. Journal of the American Medical Association 265 ( 9 ): 1145 – 51.en_US
dc.identifier.citedreferenceGrundy, S.M., R.B. D'Agostino Sr., L. Mosca, G.L. Burke, P.W. Wilson, D.J. Rader, J.I. Cleeman, E.J. Roccella, J.A. Cutler, and L.M. Friedman. 2001. Cardiovascular Risk Assessment Based on US Cohort Studies: Findings from a National Heart, Lung, and Blood Institute Workshop. Circulation 104: 1 – 6.en_US
dc.identifier.citedreferenceHayward, R.A., D.M. Kent, S. Vijan, and T.P. Hofer. 2005. Reporting Clinical Trial Results to Inform Providers, Payers, and Consumers: Conventional Analyses of Clinical Trials Can Underestimate Potential Risks and Benefits to Patients. Health Affairs 24 ( 6 ): 1571 – 81.en_US
dc.identifier.citedreferenceHayward, R.A., D.M. Kent, S. Vijan, and T.P. Hofer. 2006. Multivariable Risk Prediction Can Greatly Enhance the Statistical Power of Clinical Trial Subgroup Analysis. BMC Medical Research Methodology 6: 18.en_US
dc.identifier.citedreferenceHeart Protection Study Collaborative Group. 2002. MRC/BHF Heart Protection Study of Cholesterol Lowering with Simvastatin in 20,536 High-Risk Individuals: A Randomised Placebo-Controlled Trial. Lancet 360 ( 9326 ): 7 – 22.en_US
dc.identifier.citedreferenceHense, H.W., H. Schulte, H. LÖwel, G. Assmann, and U. Keil. 2003. Framingham Risk Function Overestimates Risk of Coronary Heart Disease in Men and Women from Germany—Results from the MONICA Augsburg and PROCAM Cohorts. European Heart Journal 24: 937 – 45.en_US
dc.identifier.citedreferenceIoannidis, J.P.A., and J. Lau. 1998. Heterogeneity of the Baseline Risk within Patient Populations of Clinical Trials: A Proposed Evaluation Algorithm. American Journal of Epidemiology 148 ( 11 ): 1117 – 26.en_US
dc.identifier.citedreferenceJacobson, T.A., J.R. Schein, A. Williamson, and C.M. Ballantyne. 1998. Maximizing the Cost-Effectiveness of Lipid-Lowering Therapy. Archives of Internal Medicine 158: 1977 – 89.en_US
dc.identifier.citedreferenceKent, D.M., and D.M. Hayward. 2007. Why Summary Results from Clinical Trials Often Mislead Doctors Taking Care of Individual Patients, and Why Risk Stratification of Clinical Trial Results Should Be Required. Journal of the American Medical Association 298 ( 10 ): 1209 – 12.en_US
dc.identifier.citedreferenceKent, D.M., R.A. Hayward, J.L. Griffith, S. Vijan, J.R. Beshansky, R.M. Califf, and H.P. Selker. 2002. An Independently Derived and Validated Predictive Model for Selecting Patients with Myocardial Infarction Who Are Likely to Benefit from Tissue Plasminogen Activator Compared with Streptokinase. American Journal of Medicine 113 ( 2 ): 104 – 11.en_US
dc.identifier.citedreferenceKnuiman, M.W., M.L. Divitini, J.S. Buzas, and P.E.B. Fitzgerald. 1998. Adjustment for Regression Dilution in Epidemiological Regression Analyses. Annals of Epidemiology 8 ( 1 ): 56 – 63.en_US
dc.identifier.citedreferenceKottke, T.E., P. Puska, J.T. Salonen, J. Tuomilehto, and A. Nissinen. 1985. Projected Effects of High-Risk versus Population-Based Prevention Strategies in Coronary Heart Disease. American Journal of Epidemiology 121 ( 5 ): 697 – 704.en_US
dc.identifier.citedreferenceKrahn, M., C.D. Naylor, A.S. Basinski, and A.S. Detsky. 1991. Comparison of an Aggressive (U.S.) and a Less Aggressive (Canadian) Policy for Cholesterol Screening and Treatment. Annals of Internal Medicine 115 ( 4 ): 248 – 55.en_US
dc.identifier.citedreferenceKravitz, R.L., N. Duan, and J. Braslow. 2004. Evidence-Based Medicine, Heterogeneity of Treatment Effects, and the Trouble with Averages. The Milbank Quarterly 82 ( 4 ): 661 – 87.en_US
dc.identifier.citedreferenceLaRosa, J.C., J. He, and S. Vupputuri. 1999. Effect of Statins on Risk of Coronary Disease: A Meta-Analysis of Randomized Controlled Trials. Journal of the American Medical Association 282: 2340 – 46.en_US
dc.identifier.citedreferenceLe Goff, J.M., L. Lavayssiere, J. Rouesse, and F. Spyratos. 2000. Nonlinear Discriminant Analysis and Prognostic Factor Classification in Node-Negative Primary Breast Cancer Using Probabilistic Neural Networks. Anticancer Research 20: 2213 – 18.en_US
dc.identifier.citedreferenceLeitha, T., A. Staudenherz, B. Bachmann, and R. Dudczak. 1994. Effectiveness of Coronary Heart Disease Risk Management in High-Risk Patients. Clinical Cardiology 17 ( 3 ): 123 – 30.en_US
dc.identifier.citedreferenceLiu, J., Y. Hong, R.B. D'Agostino Sr., Z. Wu, W. Wang, J. Sun, P.W.F. Wilson, W.B. Kannel, and D. Zhao. 2004. Predictive Value for the Chinese Population of the Framingham CHD Risk Assessment Tool Compared with the Chinese Multi-Provincial Cohort Study. Journal of the American Medical Association 291 ( 21 ): 2591 – 99.en_US
dc.identifier.citedreferenceMacMahon, S., R. Peto, J. Cutler, R. Collins, P. Sorlie, J. Neaton, R. Abbott, J. Godwin, A. Dyer, and J. Stamler. 1990. Blood Pressure, Stroke, and Coronary Heart Disease. Part 1, Prolonged Differences in Blood Pressure: Prospective Observational Studies Corrected for the Regression Dilution Bias. Lancet 335 ( 8692 ): 765 – 74.en_US
dc.identifier.citedreferenceManuel, D.G., J. Lim, P. Tanuseputro, G.M. Anderson, D.A. Alter, A. Laupacis, and C.A. Mustard. 2006. Revisiting Rose: Strategies for Reducing Coronary Heart Disease. British Medical Journal 332 ( 7542 ): 659 – 62.en_US
dc.identifier.citedreferenceMoscucci, M., E. Kline-Rogers, D. Share, M. O'Donnell, A. Maxwell-Eward, W.L. Meengs, P. Kraft, A.C. DeFranco, J.L. Chambers, K. Patel, J.G. McGinnity, and K.A. Eagle. 2001. Simple Bedside Additive Tool for Prediction of In-Hospital Mortality after Percutaneous Coronary Interventions. Circulation 104: 263 – 68.en_US
dc.identifier.citedreferenceNational Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2002. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 106 ( 25 ): 3143 – 421.en_US
dc.identifier.citedreferenceNowels, D., J. McGloin, J. Westfall, and S. Holcomb. 2005. Validation of the EQ-5D Quality of Life Instrument in Patients after Myocardial Infarction. Quality of Life Research 14 ( 1 ): 95 – 105.en_US
dc.identifier.citedreferencePignone, M., C. Phillips, and C. Mulrow. 2000. Randomised Trials of Coronary Heart Disease: Meta-Analysis of Use of Lipid Lowering Drugs for Primary Prevention. British Medical Journal 321: 983 – 86.en_US
dc.identifier.citedreferencePocock, S.J., V. McCormack, F. Gueyffier, F. Boutitie, R.H. Fagard, and J.P. Boissel. 2001. A Score for Predicting Risk of Death from Cardiovascular Disease in Adults with Raised Blood Pressure, Based on Individual Patient Data from Randomised Controlled Trials. British Medical Journal 323: 75 – 81.en_US
dc.identifier.citedreferenceRevicki, D.A., and M. Wood. 1998. Patient-Assigned Health State Utilities for Depression-Related Outcomes: Differences by Depression Severity and Antidepressant Medications. Journal of Affective Disorders 48: 25 – 36.en_US
dc.identifier.citedreferenceRichardson, C.R., A.M. Kriska, P.M. Lantz, and R.A. Hayward. 2004. Physical Activity and Mortality across Cardiovascular Disease Risk Groups. Medicine & Science in Sports & Exercise 36 ( 11 ): 1923 – 29.en_US
dc.identifier.citedreferenceRodgers, A., M. Ezzati, S. Vander Hoorn, A.D. Lopez, R.B. Lin, and C.J. Murray. 2004. Comparative Risk Assessment Collaborating Group. Distribution of Major Health Risks: Findings from the Global Burden of Disease Study. PLoS Medicine 1 ( 1 ): 44 – 55.en_US
dc.identifier.citedreferenceRose, G. 1985. Sick Individuals and Sick Populations. International Journal of Epidemiology 14: 32 – 38.en_US
dc.identifier.citedreferenceRose, G. 1992. The Strategy of Preventive Medicine. Oxford: Oxford University Press.en_US
dc.identifier.citedreferenceRothwell, P.M., and C.P. Warlow. 1999. Prediction of Benefit from Carotid Endarterectomy in Individual Patients: A Risk-Modelling Study. European Carotid Surgery Trialists' Collaborative Group. Lancet 353 ( 9170 ): 2105 – 10.en_US
dc.identifier.citedreferenceSelker, H.P., J.L. Griffith, J.R. Beshansky, C.H. Schmid, R.M. Califf, R.B. D'Agostino, M.M. Laks, K.L. Lee, C. Maynard, R.H. Selvester, G.S. Wagner, and W.D. Weaver. 1997. Patient-Specific Predictions of Outcomes in Myocardial Infarction for Real-Time Emergency Use: A Thrombolytic Predictive Instrument. Annals of Internal Medicine 127: 538 – 56.en_US
dc.identifier.citedreferenceSlotman, G.J. 2000. Prospectively Validated Prediction of Organ Failure and Hypotension in Patients with Septic Shock: The Systemic Mediator Associated Response Test (SMART). Shock 14: 101 – 6.en_US
dc.identifier.citedreferenceStamler, J., G. Rose, R. Stamler, P. Elliott, A. Dyer, and M. Marmot. 1989. INTERSALT Study Findings. Public Health and Medical Care Implications. Hypertension 14 ( 5 ): 570 – 77.en_US
dc.identifier.citedreferenceStier, D.M., S. Greenfield, D.P. Lubeck, K.A. Dukes, S.C. Flanders, J.M. Henning, J. Weir, and S.H. Kaplan. 1999. Quantifying Comorbidity in a Disease-Specific Cohort: Adaptation of the Total Illness Burden Index to Prostate Cancer. Urology 54: 424 – 29.en_US
dc.identifier.citedreferenceStrachan, D., and G. Rose. 1991. Strategies of Prevention Revisited: Effects of Imprecise Measurement of Risk Factors on the Evaluation of “High-Risk” and “Population-Based” Approaches to Prevention of Cardiovascular Disease. Journal of Clinical Epidemiology 44: 1187 – 96.en_US
dc.identifier.citedreferenceTekkis, P.P., and J.D. Poloniecki, M.R. Thompson, and J.D. Stamatakis. 2003. Operative Mortality in Colorectal Cancer: Prospective National Study. British Medical Journal 327: 1196 – 1201.en_US
dc.identifier.citedreferenceTeno, J.M., F.E. Harrell Jr., W. Knaus, R.S. Phillips, A.W. Wu, A. Connors Jr., N.S. Wenger, D. Wagner, A. Galanos, N.A. Desbiens, and J. Lynn. 2000. Prediction of Survival for Older Hospitalized Patients: The HELP Survival Model. Journal of the American Geriatric Society 48: S16 – 24.en_US
dc.identifier.citedreferenceTsevat, J., L. Goldman, G.A. Lamas, M.A. Pfeffer, C.C. Chapin, K.F. Connors, and T.H. Lee. 1991. Functional Status versus Utilities in Survivors of Myocardial Infarction. Medical Care 29 ( 11 ): 1153 – 59.en_US
dc.identifier.citedreferenceU.S. Census Bureau, Population Division/International Programs Center. 2004. Population Pyramids for the United States. Available at http://www.census.gov/ipc/www/idbpyr.html ( accessed May 26, 2007 ).en_US
dc.identifier.citedreferenceWald, N.J., and M.R. Law. 2003. A Strategy to Reduce Cardiovascular Disease by More than 80%. British Medical Journal 326 ( 7404 ): 1419.en_US
dc.identifier.citedreferenceWatts, G.F., B. Lewis, J.N. Brunt, E.S. Lewis, D.J. Coltart, L.D. Smith, J.I. Mann, and A.V. Swan. 1992. Effects on Coronary Artery Disease of Lipid-Lowering Diet, or Diet plus Cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS). Lancet 339 ( 8793 ): 563 – 69.en_US
dc.identifier.citedreferenceWilson, P.W., J.B. Meigs, L. Sullivan, C.S. Fox, D.M. Nathan, and R.B. D'Agostino Sr. 2007. Prediction of Incident Diabetes Mellitus in Middle-Aged Adults: The Framingham Offspring Study. Archives of Internal Medicine 167 ( 10 ): 1068 – 74.en_US
dc.identifier.citedreferenceZimmerman, J.E., D.P. Wagner, E.A. Draper, L. Wright, C. Alzola, and W.A. Knaus. 1998. Evaluation of Acute Physiology and Chronic Health Evaluation III Predictions of Hospital Mortality in an Independent Database. Critical Care Medicine 26: 1317 – 26.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1468-0009.2008.00534.x.pdf
Size:
155.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.